Company

Enterome Bioscience

Laboratory: 5 rue Henri Desbruères
Genopole Campus 1 – Building 7
91000 EVRY – FRANCE
Phone: +33 (0)1 75 77 27 85
Email: info@enterome.com

Pierre BELICHARD: CEO

Web Site >

#Health / Well-being #Therapeutics

Intestinal microbiota
IBD
Immunotherapy
Innovation
Metagenomics

Field of Activity

Enterome develops and commercializes therapies for disorders associated with disruption of the intestinal microbiota.

BACKGROUND
Enterome is the result of scientific breakthroughs made at Inra. The company has carried out research in the quantitative metagenomics of the intestinal microbiota, empowering in turn the development of more recently novel therapies.
DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
Technologies:
Quantitative metagenomics and functional metagenomics platforms, biological research laboratories.
Products:
Candidate treatments and complementary diagnostics for chronic inflammatory bowel diseases and various forms of cancer.
ACCOMPLISHMENTS / COLLABORATIONS / HIGHLIGHTS
Collaborative research partnerships with the pharmaceutical industry:

Takeda Pharmaceutical,
Bristol-Myers Squibb.

Further information

Number of patents: 16 proprietary and 3 licenses
Number of employees: 60
Strengths:
– €63.8 M in raised funds. Key programs in inflammatory bowel diseases/cancer in clinical development.
– Innovative therapies. A pioneer in the field.

Genopole’s Companies

#Health / Well-being

In same field

Orinova

is developing a breakthrough innovation in oncology with a patented nanomedicine incorporating a unique dual therapy: a chemotherapy molecule combined with gold nanoparticles.

AGS Therapeutics

AGS Therapeutics is a biotech company pioneering the use of microalgae extracellular vesicles (MEVs) as a universal delivery system for innovative therapeutics, vaccines and gene therapies.

5 H 45

A protein-based nanofilm technology offers the first non-toxic, semi-permanent hair treatment that allows users to safely change their hair style without damage.

BioHive - Genopole Company Shaker - Gene.iO

BioHive

BioHive provides advanced analysis for dermatological products using innovative skin organoids derived from human stem cells, for toxicity and efficacy evaluations.

Alt Biotech - Genopole's Company Gene.iO#3

Alt Biotech

Alt Biotech offers an innovative bioproduction platform for non-therapeutic recombinant proteins: productive, scalable, with low environmental impact

Vitropep

Vitropep developed a unique technology allowing to inject certain peptides without cold chain and with self-administration.

Exosome Analytics - Entreprise génopolitaine

Exosome Analytics

Exosome Analytics develops techniques for EVs isolation and highly sensitive detection of protein markers on EVs for their application in liquid biopsy.

bYoRNA

Platform for the bioproduction of RNA through fermentation in eukaryotic cells, a paradigm shift from in vitro synthesis

Kyron.Bio - Genopole's Company

Kyron.Bio

Kyron.Bio is a biotech company using synthetic biology to produce new therapies with high yield, activity, and stability standards.

CGenetix - Entreprise génopolitaine

CGenetix

CGenetix, is a medTech start-up developing in vitro medical diagnostic devices for the follow-up of transplant patients.

EndoGene.Bio - Genopole's Company

EndoGene.Bio

Research & development for an in vitro diagnostic tool for endometriosis

Exosome Analytics - Entreprise génopolitaine

Exosome Analytics

Exosome Analytics develops techniques for EVs isolation and highly sensitive detection of protein markers on EVs for their application in liquid biopsy.

Maison M - Startup génopolitaine

Maison M

Personalized and sustainable Cosmetic House inspired by various and unique beauties. The innovative Maison M lipstick delivers any shade customized by its user.

Cell Environment - Genopole's company

Cell Environment

Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.

Innovhem - Entreprise génopolitaine

Innovhem

Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell Disease

StemSelect - Entreprise génopolitaine

StemSelect

The aim of StemSelect is to pave the way for a general access to cell therapy. The company develops a rapid isolation method of stem cells derived from one’s own fat tissue.

Synsight - Genopole's Company

Synsight

Synsight is a company specializing in the discovery and preclinical development of new therapeutic molecules, based on a proprietary, integrated platform, combining artificial intelligence, molecular modeling and a functional experimental screening approach of High-Content Screening (HCS ).

Sebia - Genopole's Company

Sebia

Design, manufacture and commercialization of in vitro diagnostic systems (instruments and reagents) for medical biology laboratories.

IntegraGen - Genopole's Company

Integragen

IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.

Généthon - Genopole's Laboratory

Généthon

Discovery, development and production of innovative therapies for rare genetic diseases, notably neuromuscular diseases.

View all >

With the support from

Région île de France

Ministère de l'Enseignement supérieur et de la recherche

AFM-Téléthon

Communauté d'agglomération Grand Paris Sud

Département de l'Essonne - Terre D'avenirs

Ville d'Evry-Courcouronnes
2023

Centre hospitalier Sud Francilien

Université d'Evry - Paris Saclay

Université PAris-Saclay